Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment.
- DOI
- 10.37765/ajmc.2026.90025
- Published
- 2026 Oct
- Container
- The American journal of managed care
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.37765/ajmc.2026.90025,
title = {Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment.},
author = {Eber MR and Costa R and Argetsinger S and Shahzad M and Zhang F and Wharam JF and Ross-Degnan D and Wagner AK},
year = {2026},
journal = {The American journal of managed care},
doi = {10.37765/ajmc.2026.90025},
url = {https://doi.org/10.37765/ajmc.2026.90025}
}RIS
TY - JOUR TI - Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment. AU - Eber MR AU - Costa R AU - Argetsinger S AU - Shahzad M AU - Zhang F AU - Wharam JF AU - Ross-Degnan D AU - Wagner AK PY - 2026 JO - The American journal of managed care DO - 10.37765/ajmc.2026.90025 UR - https://doi.org/10.37765/ajmc.2026.90025 ER -
APA
MR, E., R, C., S, A., M, S., F, Z., JF, W., D, R., & AK, W. (2026). Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment.. The American journal of managed care. https://doi.org/10.37765/ajmc.2026.90025
Source records
- pubmed · retrieved 2026-11-10T18:08:56.959Z